Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance that occurs with pregnancy or is first discovered during pregnancy. GDM, which is the most common metabolic complication associated with pregnancy, imposes risks on both mother and fetus.
By optimizing medication use and reducing the risks of polypharmacy, the pharmacists plays a key role in decreasing morbidity and mortality in this patient population.
In the United States, the number of people diagnosed with diabetes is staggering.
Peripheral neuropathy (PN) is one of the most common complications of diabetes.
T ype 2 diabetes mellitus (DM2) results from the combination of an insulin-secretory defect and peripheral insulin resistance.
T he American Diabetes Association (ADA) defines diabetes mellitus as a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both.
Researchers at Duke University have discovered that caffeine taken in even moderate doses could impair glucose control in patients with type 2 diabetes.
Currently, there are 20.8 million people, or 7% of the U.
Diabetes mellitus (DM) currently affects an estimated 20.8 million people within the United States, with a current worldwide prevalence estimated at 180 million and which is expected to double by 2030.
Diabetes is a major public health problem that affects 7% of the United States population, or 20.8 million people.
Omega-3 Fatty Acids Reduce Risk of Type 1 Diabetes in Children Preliminary research published in a recent issue of JAMA suggests that the dietary intake of omega-3 fatty acids by children at increased genetic risk for type 1 diabetes is associated with a reduced risk of pancreatic islet autoimmunity, which is linked to the development of this disease.
Diabetes is the fifth leading cause of death worldwide.
